Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV

BACKGROUND: The initiation of antiretroviral treatment based on a 2-drug regimen (2DR) with dolutegravir plus lamivudine has demonstrated non-inferior efficacy than dolutegravir-based three-drug regimens (3DR). We aimed to assess whether the treatment initiation with this 2DR has a different impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Sanz, Javier, Ron, Raquel, Moreno, Elena, Sánchez-Conde, Matilde, Muriel, Alfonso, López Cortés, Luis Fernando, Blanco, José Ramón, Pineda, Juan Antonio, Mena, Álvaro, Calzado Isbert, Sonia, Moreno, Santiago, Serrano-Villar, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009371/
https://www.ncbi.nlm.nih.gov/pubmed/35432298
http://dx.doi.org/10.3389/fimmu.2022.873408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009371/
https://www.ncbi.nlm.nih.gov/pubmed/35432298
http://dx.doi.org/10.3389/fimmu.2022.873408

Ejemplares similares